Current price is more than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Sakar Healthcare ltd. is engaged in providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Liquid Injectables in ampoules and vials, and Dry Powder Injections.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Sakar Healthcare Limited has informed the Exchange that the management of the Company are participating in the Broker Conference hosted by Arihant Capital on 29th June, 2022. | Download
Sakar Healthcare Limited has informed the Exchange that the management of the Company are participating in the Broker Conference hosted by Arihant Capital on 29th June, 2022. | Download
Sakar Healthcare Limited has informed the Exchange about submission of advertisement published in English and Gujarati Newspapers dated 11th June, 2022 for obtaining approval of members for the proposed Resolution as set out in the Extra Ordinary General Meeting Notice dated 9th June 2022 by way of EGM in compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | Download
Sakar Healthcare Limited has informed the Exchange about submission of advertisement published in English and Gujarati Newspapers dated 11th June, 2022 for obtaining approval of members for the proposed Resolution as set out in the Extra Ordinary General Meeting Notice dated 9th June 2022 by way of EGM in compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value